Nan Fung Trinity holds a diversified book of 55 stocks worth $1.0B as of Q2 2026 (disclosed Jul 24, 2026, a ~45-day 13F lag). This quarter they opened Iren Ltd and trimmed Advanced Micro Devices. Their largest long position is Advanced Micro Devices at 7% of the equity book. Cloning the disclosed picks since 2024 would be +59% (+31.5%/yr). That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1781880/holdings"
Use Arkolith to show NAN FUNG TRINITY's latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 24.3 points over this window.
Growth of $10,000 cloning Nan Fung Trinity's disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
86% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Nan Fung Trinity
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 73 / 55 | $622.7B |
| JPMORGAN CHASE & CO | 73 / 55 | $135.5B |
| MORGAN STANLEY | 73 / 55 | $125.3B |
| UBS Group AG | 73 / 55 | $39.8B |
| ROYAL BANK OF CANADA | 73 / 55 | $34.3B |
| BNP PARIBAS FINANCIAL MARKETS | 73 / 55 | $13.9B |
| GOLDMAN SACHS GROUP INC | 72 / 55 | $67.3B |
| OSAIC HOLDINGS, INC. | 72 / 55 | $2.9B |
Ranked by how many of Nan Fung Trinity's top 55 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Advanced Micro Devices Inc COM | $67.8M | 116.7K | 6.7% | ▼−28% Reduced · −45K sh | |
| 2 | Amcor PLC COM NEW | $52.0M | 1.20M | 5.1% | ▲+7.5% Added · +84K sh | |
| 3 | PPG Inds Inc COM | $48.2M | 397.3K | 4.8% | —Held | |
| 4 | Ge Healthcare Technologies I COMMON STOCK | $40.9M | 638.7K | 4.0% | ▲+203% Added · +428K sh | |
| 5 | Nvidia Corporation COM | $36.1M | 180.2K | 3.6% | ▼−22% Reduced · −50K sh | |
| 6 | Home Depot Inc COM | $35.2M | 99.9K | 3.5% | ▲+37% Added · +27K sh | |
| 7 | KT Corp SPONSORED ADR | $33.8M | 1.96M | 3.3% | ▲+0.3% Added · +5K sh | |
| 8 | Ishares TR MSCI INDONIA ETF | $33.7M | 2.98M | 3.3% | ▲+33% Added · +745K sh | |
| 9 | Ishares TR MBS ETF | $33.0M | 349.2K | 3.3% | —Held | |
| 10 | Owens Corning New COM | $29.6M | 186.3K | 2.9% | ▲+37% Added · +50K sh | |
| 11 | Unitedhealth Group Inc COM | $28.4M | 68.3K | 2.8% | ▼−34% Reduced · −36K sh | |
| 12 | Air Products And Chemicals I COM | $28.3M | 96.7K | 2.8% | —Held | |
| 13 | Ishares TR CORE S&P MCP ETF | $27.7M | 359.0K | 2.7% | —Held | |
| 14 | America Movil SAB De CV SPON ADS RP CL B | $27.4M | 1.06M | 2.7% | ▼−20% Reduced · −267K sh | |
| 15 | Mirum Pharmaceuticals Inc COM | $27.2M | 232.7K | 2.7% | —Held | |
| 16 | Danaher Corp Del COM | $24.1M | 126.5K | 2.4% | ▲+28% Added · +28K sh | |
| 17 | Trevi Therapeutics Inc COM | $22.6M | 1.21M | 2.2% | ▲+6.2% Added · +71K sh | |
| 18 | Meta Platforms Inc CL A | $21.0M | 37.4K | 2.1% | ▲+146% Added · +22K sh | |
| 19 | Protagonist Therapeutics Inc COM | $19.7M | 160.7K | 1.9% | —Held | |
| 20 | Abivax Sa SPONSORED ADS | $18.9M | 142.1K | 1.9% | ▲+10% Added · +13K sh | |
| 21 | SPDR Series Trust ST STR SP HOME | $17.9M | 155.0K | 1.8% | —Held | |
| 22 | Jd.com Inc SPON ADS CL A | $16.6M | 649.7K | 1.6% | —Held | |
| 23 | Bridgebio Pharma Inc COM | $16.3M | 219.2K | 1.6% | —Held | |
| 24 | MP Materials Corp COM CL A | $15.9M | 283.1K | 1.6% | —Held | |
| 25 | PDD Holdings Inc SPONSORED ADS | $15.8M | 207.7K | 1.6% | ▲+36% Added · +55K sh | |
| 26 | Scholar Rock Hldg Corp COM | $15.7M | 285.5K | 1.6% | —Held | |
| 27 | Warner Bros Discovery Inc COM SER A | $15.3M | 575.7K | 1.5% | —Held | |
| 28 | Immunome Inc COM | $15.1M | 714.6K | 1.5% | —Held | |
| 29 | Xenon Pharmaceuticals Inc COM | $15.0M | 247.8K | 1.5% | —Held | |
| 30 | Iren Limited ORDINARY SHARES | $13.5M | 295.0K | 1.3% | ▲New New position | |
| 31 | Kura Oncology Inc COM | $12.9M | 1.17M | 1.3% | ▲+10% Added · +110K sh | |
| 32 | Bicara Therapeutics Inc COM | $12.7M | 427.9K | 1.3% | —Held | |
| 33 | Alexandria Real Estate Eq In COM | $12.6M | 239.0K | 1.2% | —Held | |
| 34 | Honeywell Intl Inc COM | $12.3M | 55.1K | 1.2% | ▲New New position | |
| 35 | Honeywell Aerospace Inc COM | $12.2M | 55.1K | 1.2% | ▲New New position | |
| 36 | Vor Biopharma Inc COM NEW | $11.9M | 646.5K | 1.2% | ▲New New position | |
| 37 | Flex Ltd ORD | $11.7M | 72.3K | 1.2% | ▲New New position | |
| 38 | CRH PLC ORD | $11.4M | 106.7K | 1.1% | ▲New New position | |
| 39 | Savara Inc COM | $11.3M | 1.84M | 1.1% | —Held | |
| 40 | Celcuity Inc COM | $10.9M | 103.8K | 1.1% | —Held | |
| 41 | BXP Inc COM | $8.1M | 121.9K | 0.8% | —Held | |
| 42 | Kilroy Realty Corp COM | $7.9M | 210.8K | 0.8% | —Held | |
| 43 | Vaxcyte Inc COM | $7.1M | 122.9K | 0.7% | —Held | |
| 44 | SL Green Rlty Corp COM | $6.9M | 132.5K | 0.7% | ▼−2.4% Reduced · −3K sh | |
| 45 | Zai Lab Ltd ADR | $6.6M | 346.5K | 0.6% | —Held | |
| 46 | Abeona Therapeutics Inc COM NEW | $5.9M | 956.8K | 0.6% | —Held | |
| 47 | Vornado Rlty TR SH BEN INT | $5.7M | 143.8K | 0.6% | —Held | |
| 48 | Uniqure NV SHS | $5.3M | 115.5K | 0.5% | —Held | |
| 49 | Climb Bio Inc COM | $4.7M | 360.7K | 0.5% | ▼−14% Reduced · −60K sh | |
| 50 | Biocryst Pharmaceuticals Inc COM | $4.5M | 450.0K | 0.4% | ▲New New position |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 24, 2026 | 55 | $1.0B | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 5, 2026 | 62 | $910.6M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 4, 2026 | 78 | $1.3B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 | 71 | $1.0B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 | 59 | $835.8M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 | 39 | $630.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 4, 2025 | 30 | $489.7M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 26 | $528.4M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.